Vendor, Liverpool, GBR
University of Liverpool
UEI VFHSMEHGFGG5, CAGE U5F53
4 awards and $300,053 obligated between March 14, 2025 and September 2, 2026, 50% under full and open competition, against 2.3 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Food and Drug Administration | $349,995 |
| Federal Bureau of Investigation | -$49,942 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $349,995 |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 | -$49,942 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Not Competed | 1 |
| Competed Under SAP | 1 |
| Definitive Contract | 3 |
| Purchase Order | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak
Food and Drug Administration, FDA Office of Acq Grant SVCS
SolicitationNAICS 54171475F40126Q00327Awarded to University of Liverpool
Posted Aug 4
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40126C00106Definitive Contract, September 2, 2026, Not Competed, 1 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | Eo 14398 - This Project Shall Sequence and Characterize the Genome of BDBV in the Current Outbreak, with a Specific Target to Sequence and ANAICS 541714, PSC AN13 | $349,995 |
| 75F40120C00085Definitive Contract, April 29, 2025, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | This Is a Unilateral Administrative Modification. Line Item 1 (Base) Period of Performance End Date Is Being Changed from 09/14/2023 to 09/1NAICS 541714, PSC AN91 | $0 |
| 75F40123C00191Definitive Contract, June 27, 2025, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | This Is a Firm Fixed Price Contract for Development of a Rabbit Model to Characterise Antifungal Drug Resistance.NAICS 541714, PSC R499 | $0 |
| 15F06723P0002335Purchase Order, March 14, 2025, Competed Under SAP, 6 offers | FBI-JEHFederal Bureau of Investigation | Reducing Resistance in Detainees by Enhancing Empathy in InterrogatorsNAICS 541720, PSC R499 | -$49,942 |
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental DevelopmentAN91 N – Health R&D ServicesR499 Other Professional Services
- Transactions
- 8 across 4 awards